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Introduction
Scaffold proteins play an important role in propagation of signals from cell surface receptors.
Bringing signalling proteins into proximity on a common structure provides increased opportunity for regulation of downstream response through signal specification and amplification. Initiation of signal transduction from receptor tyrosine kinases (RTKs) is dominated by tyrosine phosphorylation, however this is often superseded by serine/threonine kinase up-regulation. Juxtaposing of tyrosine and serine/threonine cognate binding sites on a scaffold protein provides the opportunity for fine-tuning of RTK signal transduction through modulating protein-protein interactions (Deribe et. al., 2010; Johnson und Lewis, 2001; Seet et. al., 2006) .
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The prototypical scaffold protein ShcA (henceforth Shc) has been extensively studied in regard to its ability to recruit proteins dynamically in RTK-mediated signalling. It plays a complex role as a hub for binding of numerous signalling proteins. Despite having no intrinsic enzyme activity, Shc is involved in signal transduction associated with poor prognosis in breast cancer patients (Ursini-Siegel & Muller, 2008) . The ShcA gene encodes three isoforms of 46, 52 and 66 kDa (p46, p52 and p66 respectively) which all possess an Nterminal PTB domain and a C-terminal SH2 domain which sequentially sandwich a CH1 domain. Shc binds through its phosphotyrosine binding (PTB) domain to tyrosyl phosphates on activated RTKs and undergoes a conformational change which exposes its SH2 domain (George et. al., 2008) . Within the sequence of Shc are a number of tyrosine, serine and threonine phosphorylation sites which enable Shc to recruit a large, multi-functional array of proteins which appear to be temporally controlled subsequent to RTK activation (Zheng et. al., 2013) . Shc therefore forms a dynamic hub for protein recruitment.
It has been demonstrated that under non-stimulated conditions Shc (p52Shc) binds directly to the proline-directed serine/threonine kinase, Erk (extracellular signal-regulated kinase, aka. mitogen-activated protein kinase (MAPK)) . In so doing Erk is restricted from engaging in MAPK signalling. Erk is released from Shc and becomes upregulated in response to RTK-activated MAPK signalling. On activation Erk phosphorylates a wide range of downstream effector protein substrates (Arur et. al., 2009; Carlson et. al., 2011) , including several scaffold proteins, e.g. Grb2-associated binding protein 1 (Gab1) (Gu und Neel, 2003; Lehr et. al., 2004; Roshan et. al., 1999; Yu et. al., 2002) , fibroblast growth factor receptor substrate alpha Frs (Lax et. al., 2002; Wu et. al., 2003) and insulin 4 receptor substrate 1 (IRS1) (Arur et. al.., 2009; De Fea et. al., 1997) . While Shc has recently been established to be a substrate for Erk, the significance of these phosphorylation events has not been investigated (Zheng et. al., 2013) . Erk-mediated phosphorylation of Shc could regulate its ligand binding capability allowing modulation of downstream signalling.
Serine/threonine and tyrosine phosphorylation are considered to be inversely correlated events, for example phosphorylation on serine/threonine residues of a scaffold protein reduces the level of tyrosine phosphorylation. Since phosphorylated tyrosine residues are required to propagate downstream signalling from a RTK, reduction in signalling through subsequent serine/threonine phosphorylation results in a negative feedback mechanism for pathway control (Lax et. al., 2002; Yu et. al., 2002) . Interestingly, a positive feedback role for serine/threonine phosphorylation on scaffold proteins has also been shown. For example, Erk phosphorylation of Gab1 enhances the recruitment of the p85 subunit of phosphoinositide 3-kinase (PI3K) to Gab1, resulting in an increase in PI3K and Erk signalling (Yu et. al., 2001 ).
Here we show that three threonine residues on Shc are selectively phosphorylated by Erk in vitro and in breast cancer cell lines post-EGF stimulation. Phosphorylation of these residues leads to elevated Erk and Akt phosphorylation post-EGF stimulation. We demonstrate how phosphorylation on one of these residues appears in two selected triple-negative breast cancer cell lines and investigate the structural implications of these phosphorylation events.
We identify two proteins whose phosphothreonine-dependent association with Shc provides evidence for additional downstream signal mediation.
Results

Three threonine residues on Shc are substrates for Erk
Three threonine residues on Shc (T214, T276 and T407) are contained within the Erk consensus substrate sequence (S/T-P). Incubation of purified Shc with active Erk2 in the presence of ATP and MgCl2 revealed that Shc is threonine phosphorylated on the putative Erk substrate sites ( Figure 1A ). Since the commercially available pan-anti-T-P antibody cannot distinguish between the three substrate sites for Erk on Shc, we analysed Erkphosphorylated, trypsin-digested Shc by mass spectrometry. This showed that three T-P motifs on p52Shc were phosphorylated after incubation with Erk (Supplemental Figure 1 ).
Of the three sites only T214 has previously been shown to be a substrate for Erk (Zheng et. al., 2013) . Phosphorylation of T276 on p66Shc by an unknown kinase (Khanday et. al., 2006; Rajendran et. al., 2010) has previously been reported. T214 and T276 are found in the CH1 domain, whilst T407 is in the SH2 domain ( Figure 1B ). Both T214 and T407 are highly conserved across various species, whereas T276 is less so ( Figure 1C ).
Since phosphorylation of Shc has previously been shown to exert regulatory control of ligand binding (George et. al., 2008) , we investigated whether the phosphorylation of threonine residues affected the ability of Shc to bind to a RTK. We expressed and purified a triple mutant form of Shc in which the three threonine residues were replaced by the phosphorylation charge mimetic of threonine; glutamate (T214/276/407E or TE Shc) and measured its binding to a known Shc-binding peptide corresponding to the TrkA receptor.
The mutation of the threonine residues to glutamate mimics the triple phosphorylated state of Shc. Isothermal titration calorimetric (ITC) data show that the phosphorylation state of the threonine residues has no effect on recruitment to the receptor demonstrated by the comparable dissociation constants for the binding wild type, WT Shc, or TE Shc to the RTKderived peptide (Kd ~ 54nM and 38nM, respectively; Figure 1D ).
We previously reported a gating mechanism driven by tyrosine phosphorylation on Shc, whereby the SH2 domain is only available for ligand-binding when the CH1 domain is phosphorylated on its tyrosine residues (George et. al., 2008) . It has also been proposed that phosphorylation on Y317 introduces rigidity to the protein and limits the dynamic motions of the PTB and SH2 domains in molecular dynamics simulation studies (Suenaga et. al., 2009 (Suenaga et. al., , 2004 . Hence, there is a precedent for regulation imposed by inter-domain interactions. We therefore explored the possibility that threonine phosphorylation induces a conformational change in Shc. The structural model of the full length Shc protein suggests that T214 and T276 reside on helices (PDB 1WCP) (Suenaga et. al., 2004) . We therefore employed circular dichroism spectroscopy (CD) to investigate the effect of threonine phosphorylation on the secondary structure of Shc. We compared the CD signals from the full length unphosphorylated and threonine-phosphorylated Shc. As expected the CD signal is commensurate with the full length Shc protein (ShcFL) containing -helical -strand and disordered structure (Supplemental Table 1 ). However, no significant changes in the structural composition between unphosphorylated and threonine-phosphorylated forms were observed as shown by the overlapping signals from the wild type and mutant Shc proteins ( Figure 1E ). A further lack of impact on the protein structure was reflected in the thermostability of Shc which was unaffected by threonine phosphorylation Shc ( Figure 1F ).
Finally, the similar pattern of protease digestion observed for the WT Shc and TE Shc proteins (Fontana et. al., 2004) confirmed that no structural variation was imparted by threonine phosphorylation (Supplemental Figure 2) .
Phosphorylation of T214 is prevalent in triple-negative breast cancer cells
To investigate the potential pathological relevance of the threonine phosphorylation events we screened for the presence of phosphorylation on T214 (pT214) in a number of transformed/cancer cell lines with a specific antibody against pT214 (efficiency of antibody shown in Supplemental Figure 3 ). We initially focused on breast cancer due to the previously 
Shc threonine phosphorylation up-regulates Erk and Akt phosphorylation
Given that Shc is threonine phosphorylated in the metastatic cell lines MDA-MB-468 and MDA-MB-231 (Jin et. al., 2012; Kang et. al., 2003; Kathryn et. al., 2012) but not the nontransformed MCF10A cells (Debnath et. al., 2003) , we hypothesise that Shc threonine phosphorylation contributes towards the cellular signalling that is responsible for the oncogenic properties reflected in these cell lines. To test this hypothesis we mutated all 9 three threonine residues (T214/276/407) either to alanine ( TA Shc: phosphorylationdeficient mutant) or glutamate residues ( TE Shc: phosphorylation-mimetic mutant) and stably over-expressed these constructs in HEK293T cells. Both EGFR and Shc regulate tumorigenic signalling via the Erk and Akt pathways (Herbst, 2004; Manning & Cantley, 2007; Roberts & Der, 2007; Ursini-Siegel et. al., 2012; Wills & Jones, 2012 Frs2 (Lax et. al., 2002; Wu et. al., 2003) . The level of Akt phosphorylation was also seen to be affected by the presence of threonine phosphorylation. We observed a pronounced 3C and Supplemental Figure 6 ). Therefore a cross-talk mechanism exists between the Erk and Akt signalling pathways whereby Erk-mediated phosphorylation of Shc upregulates Akt activity. This is an unexpected result because previous reports suggested that expression of the T214A phosphorylation-deficient Shc mutant led to only a moderate increase in cell numbers when compared with wild-type Shc (Zheng et. al., 2013) , which might be indicative of downregulation of proliferative Akt signalling when Shc is threonine phosphorylated.
Furthermore, TE Shc is able to 1) elicit Akt phosphorylation even in the absence of EGF stimulation and 2) sustain Akt phosphorylation for longer than Erk phosphorylation. Both of these observations suggest the primary role of Shc threonine phosphorylation is to modulate the Akt pathway. The relatively mild positive feed-back loop that Shc and Erk engage in could be a by-product of the excess Akt activation that led to a delay in Erk dephosphorylation, possibly due to limiting common components (Mendoza et al., 2011) .
The fact that TE Shc upregulates Akt phosphorylation without the activation of Erk indicates that TE Shc is able to directly recruit downstream factors that lead to Akt activation. We note that both Erk and Akt phosphorylation levels are similar between WT Shc and TA Shc cells. This is consistent with the observation that there is no or a very low level of Shc threonine phosphorylation in HEK293T cells (Supplemental figure 4C ).
Protein recruitment is dependent on threonine phosphorylation of Shc
A large array of proteins bind to phosphorylated threonines or serines (Seet et. al., 2006; Yaffe & Elia, 2001 ). We performed a literature search to identify proteins that would be potential ligands for Shc after threonine phosphorylation. We selected three isoforms of the scaffold protein 14-3-3 (Fu et. al., 2000) , the E3 ubiquitinase, neural precursor cell expressed developmentally down-regulated protein 4, Nedd4 (Ingham et. al., 2004) and peptidyl-prolyl cis-trans isomerase NIMA-interacting 1, Pin1 Pinton et. al., 2007; Zheng et. al., 2013) as possible candidates. 14-3-3 proteins are known to binding to phosphorylated threonines and serines, while both Nedd4 and Pin1 contain WW domains that recognize either proline-rich or pThr/Ser motifs. These proteins were over-expressed, isolated and immobilized on agarose beads through fusion tags, and used as bait for pull-down experiments. Cell lysates from the MDA-MBcell line were used for fishing since Shc is threonine phosphorylated within 5 minutes of EGF stimulation in these cells (Figure 2A ). Cells were starved overnight and then stimulated with EGF for 5 minutes. Erk activity was inhibited by the use of the Mek inhibitor U0126 to abolish Erk mediated Shc threonine phosphorylation.
All proteins tested were able to pull-down Shc (Figure 4 ). Nedd4 binds to Shc constitutively, which suggests that the interaction is driven by the proline-rich motifs within the CH1 domain of Shc rather than phosphorylation ( Figure 4A ). All three 14-3-3 isoforms could bind to threonine phosphorylated Shc in an EGF stimulation-dependent manner although they were differentially affected by Erk activity ( Figure 4B and 4C). When Erk activity is inhibited the isoform interaction with Shc is reduced whereas the binding between Shc and 14-3-3 and 14-3-3 remained unchanged. 14-3-has been previously reported to up-regulate PI3K signalling when recruited to Shc (Ursini-Siegel et. al., 2012) , it is therefore likely that threonine-phosphorylated Shc augments Akt phosphorylation by interacting with 14-3-Finally, Pin1 interacts with Shc when cells are stimulated with EGF and the binding is abolished when Erk activity is inhibited. This is consistent with the fact that Pin1 binding and activity are pT/S-dependent. A C113A mutation in Pin1, which has been identified as affecting the isomerase activity without affecting binding to pT (Ranganathan et. al., 1997) , did not affect its binding to Shc ( Figure 4D ).
For proteins whose binding to Shc rely on Erk activation and hence indicating a Shcthreonine-dependent mechanism, we further tested for their ability to interact with the Shc phospho-mimic ( TE Shc) in HEK293T cells. Both Pin1 and 14-3-3 pulldown with TE Shc at a higher level than TA Shc (Supplemental Figure 7 and 8) . Therefore, we surmise that Pin1 and 14-3-3 bind to threonine phosphorylated Shc.
We used microscale thermophoresis, MST, to measure the binding of 14-3-(Supplementary Figure 5A -C) and Pin1 (Supplementary Figure 5D and E) to phosphopeptides containing the sequences including and proximal to pT214, pT276 and pT407. Fluorescently-labelled 14-3-or Pin were incubated with the individual Shc phosphothreonine peptides. Although none of the three Shc threonine phosphorylation sites include the canonical binding sequence for 14-3- (Fu et. al., 2000) , we detected binding between 14-3-and both pT (Kd=9.8µM) and pT407 (Kd=2.1µM). To confirm 14-3-is able to interact with pT407 within the context of a folded protein domain, we purified Shc SH2 domain with a phospho-mimic mutation (T407E; herein referred to as SH2TE) and measured the binding. In agreement with the peptide data, 14-3-binds to Shc SH2TE with a similar affinity as with pT407 (Kd=1.9µM; Supplementary Figure 5F ). Unlike 14-3-, Pin1 appears to show a preference for the pT407 (Kd=39µM) over the pT214 (Kd=575µM) peptides, suggesting that the sequences flanking the pT contribute to the binding affinity for the two proteins.
Discussion
In this investigation we demonstrate that the role of Shc in signal transduction is greater than just a passive scaffold Through phosphorylation by Erk and binding to selective activation. For example, the serine/threonine phosphatase PP2A, which has been shown to interact with Shc, is downregulated in breast cancer cells (Seshacharyulu et al., 2013) . It is possible that the activity of PP2A is higher in certain cell lines and therefore dephosphorylation of the pathways occur more quickly and Shc T214 phosphorylation is thus too transient to be captured in our experimental setup. Indeed, it has been shown that in MDA-MB-231, but not MCF7, cells that PP2A is inactivated by the over-expression of its inhibitor CIP2A and that tamoxifen treatment leads to the activation of PP2A and downregulation of Akt phosphorylation (Liu et. al.., 2014) .
Threonine phosphorylation does not appear to induce any structural perturbation (as has been observed on tyrosine phosphorylation (George et. al., 2008) ) even though two of the residues are in the intrinsically disordered CH1 domain. However, the formation of these new phospho-motifs alter protein recruitment. We identified two proteins, Pin1 and 14-3-3 whose binding to Shc is pT-dependent. Previous reports show that 14-3-binding to the SH2 domain of Shc is mediated by the phosphorylation of 14-3-on tyrosine 179 which 14 leads to upregulation of PI3K and subsequently Akt signalling (Barry et. al., 2009; UrsiniSiegel et. al., 2012) . Our data suggest an additional mechanism for this interaction whereby 14-3-3 binds to threonine phosphorylated Shc Recruitment of 14-3-3 to Shc has been shown to increase PI3K signalling (Ursini-Siegel et. al., 2012) . Given that PI3K is an upstream activator of Akt, it seems likely that this interaction is at least partially responsible for the elevated pAkt level seen in TE Shc cells (Vanhaesebroeck et. al., 2012) .
Pin 1 isomerizes only phospho-serine/threonine-proline motifs and plays a role as a postphosphorylation regulator of protein function and hence is implicated in cancer. Pin1 has previously been shown to recruit p66Shc to the mitochondria in a PKC-dependent manner, which is a process that leads to apoptosis (Pinton et. al., 2007) . Here we show that p52Shc
can also bind to Pin1, albeit through different phosphothreonine residues. Some peptide prolyl cis-trans isomerases (PPIases), such as Pin1 specifically catalyse isomerisation of prolines preceded by pS/pT. PPIases catalyse the conversion of the cis-trans conformation of proline which can potentially switch local conformations from one to another (Lu & Zhou, 2007) and adjust protein-recruitment profiles. In addition, because some phosphatases, such as PP2A, only act on certain phospho-isoforms, proline-isomerization can also alter the rate of phosphorylation/dephosphorylation (Lu & Zhou, 2007; Zhou et. al., 2000) . We have previously identified another PPIase, cyclophilin A (CypA) as a direct binding partner for Shc (George et. al., 2009) . Given that the CH1 domain is proline-rich, there is a strong possibility that proline isomerization provides an additional mode of regulation.
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Finally, in light of the finding that the level of Shc threonine phosphorylation is higher in two TNBC cell lines, the Shc threonine phosphorylation sites could potentially serve as markers for a subtype of TNBC. The two TNBC cell lines in which we found pT214 to be significantly phosphorylated exhibit over-expression of EGFR and mutant KRAS expression (Kathryn et. al., 2012; Kenny et. al., 2007) . While TNBC describes a collection of disease states with highly variable genotypes, some can be classified in sub-groups by other markers, such as their EGFR expression status (Ferraro et. al., 2013; Park et. al., 2014) . If this threonine phosphorylation effect is reproduced in other TNBC this could provide a viable basis for biomarker development.
Materials and Methods
Reagents
Antibodies for pErk (4695), Erk (4377), pT308Akt (4056), Akt (4691), pT-P (9391), pY239/240Shc (2434), EGFR (2646), GST (2625), 14-3-3 (8312) were obtained from Cell Signaling Technology; pY317 (sc-23765R), HA-tag (sc-805), GFP (sc-9996) were obtained from Santa Cruz; Shc (MAB0807) and Strep-tag (PAB-16601) was obtained from Abnova.
The custom antibody for pT214 Shc was generated against peptide NPPKLVpTPHDRMAG by Genscript. Lysis buffer: 50mM HEPES, pH7.5, 50mM NaCl, 1mM EGTA, 10% (w/v) Glycerol, 1mM Sodium orthovanadate, 10mM Sodium fluoride, 0.1% NP-40, 1x protease and phosphoSTOP inhibitors (Roche). Shc phosphothreonine peptides (pT214:
CNPPKLVpTPHDRMAG; pT276: CARPTAPNAQpTPSHL; pT407: CDFLVRESTTpTPGQ were purchased from Genescript.
Mammalian cell culture
HEK293T, MCF7, MDA-MB-468, MDA-MB-231, A431, PC12 cells were maintained as described previously ; MDA-MB-361 cells was grown in DMEM/F12
supplemented with 10% FBS. MCF10A cells were grown as previously described (Debnath et. al., 2003) . Transfection HEK293T cells and generation stable cell lines were described previously .
Molecular biology
TA Shc and TE Shc mutants were generated by site-mutagenesis. The following constructs were obtained from Addgene: GST-tagged 14-3-3 (13279), GST-tagged 14-3-3 (13281), and 14-3-3 (mouse; 1942), GST-Pin1 (19027) , HA-Nedd4 (27002), His-tagged Pin1 (40773). A mutation of P112A was made in mouse 14-3-3 zeta to match the human sequence and was then subcloned into the pEGFP-N vector. C113A mutation was made in GST-Pin1 by sitedirected mutagenesis.
In vitro Erk2 phosphorylation of full length Shc (ShcFL)
l of M purified ShcFL proteins in PBS were incubated with l of active Erk NEB P6080) in the presence of 5mM buffered ATP and 10mM MgCl2 overnight.
Protein expression and purification
To express and purify GFP-14-3-3 and HA-Nedd4, HEK293T cells were transfected with 20 ug of GFP-N-14-3-plasmids on a cm-dish. 2x 10cm-dishes were used per pull-down experiment. Cells were harvested and lysed in 1ml of lysis buffer 48hrs after transfection.
Cleared lysates was incubated with 50ul GFP-trap beads overnight. Beads were washed with 1ml lysis buffer 5-10 times. Recombinant his-tagged Shc was expressed and purified as described previously (George et. al., 2008) . Phosphorylated his-tagged Shc was purified with the additional step of IMAC to remove active Erk2. GST-tagged proteins and His-tagged Pin1 were expressed in Rosetta 2. Bacterial culture was inoculated with overnight culture in 1:1000 ratio and grown to OD600 0.8 at 37 o C. The temperature was then reduced to 20 o C and induced with 0.1mM IPTG for overnight. His-tagged Pin1 was purified first by affinity chromatography, followed by a size exclusion step to exchange into final buffers. GST-tagged proteins were immobilized on glutathione-sepharose resins and washed extensively in 50mM Tris pH8.0, 150mM NaCl and 0.1% Triton-X100. GST-proteins were then stored at -20 in 50% glycerol until required.
Pull-down experiments
Purified proteins immobilized on beads were incubated with MDA-MB-468 cell lysates overnight. 500ug of lysates were used per pull-down. Samples were then washed in 3x1ml lysis buffer and then boiled in Laemmli buffer before analysed by SDS-PAGE and western blotting.
Immunoprecipitation
Cells were lysed in lysis buffer (typically 1ml of lysis buffer was used on a 10cm-dish) and cleared by centrifugation. One milligram of lysate was used per IP experiment. IP antibody was added to the lysate and incubated for overnight. 25 µl of Protein A/G slurry was added to the lysate for 2 h. The immunoprecipitants were washed three times with lysis buffer and boiled with 2× sample buffer for 5 min to elute.
Isothermal titration calorimetry, ITC, experiment
Experiments were performed using the VP instrument (GE, Northampton, MA) at 13 °C in 20 mM (EPES p( mM NaCl mM EDTA and mM ME )TC binding data were corrected for heats of dilution. ORIGIN7 software was used for data analysis using the single site model.
Microscale thermophoresis, MST, experiment
Protein was labeled using the Nanotemper labeling kit Briefly ShcPTB was diluted to M in labeling buffer to the final volume of l M of dye NT-647 was added to the diluted protein and incubated for 2-4hrs at room temperature. ShcPTB was then separated from the free dye using a G25-sephadex column in PBS. Labeling efficiency was typically between 50%-100%. To test binding between ShcPTB and ligands, a 1:2 dilution series of each ligand was prepared with a final volume of l Experiments were carried out at 25 o C.
Circular dichroism, CD, spectroscopy
All CD spectra were recorded at room temperature a Jasco J-810 spectropolarimeter in PBS.
Data was collected at 0.2nm intervals in triplicates. Samples were analyzed by SDS-PAGE, followed by silver staining. Analysis of the CD signals from ShcFL proteins was analyzed by the CDSSTR software (Fontana et. al., 2004 ) ShcFL proteins are composed of -helices, -strand, turns and disordered regions. Both WT Shc and TE Shc have similar compositions.
Differential scanning fluorescence analysis
